# 'ADVANCE' (A Pilot Trial)

> **NCT03858322** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 41 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Cyclophosphamide
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT03858322
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-21
- **Primary completion:** 2020-11-10
- **Final completion:** 2026-06-30
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03858322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03858322, "'ADVANCE' (A Pilot Trial)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03858322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*